McKenzie Crist

3PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.

|Feb 21, 2023
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial.

Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz

|Nov 03, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.

McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry

Pageof 1